Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

8.76
Delayed Data
As of 10:48am ET
 -0.21 / -2.34%
Today’s Change
4.72
Today|||52-Week Range
9.72
+56.43%
Year-to-Date

Today’s Trading

Previous close8.97
Today’s open9.00
Day’s range8.52 - 9.00
Volume92,769
Average volume (3 months)124,360
Market cap$228.5M
Dividend yield--
Data as of 10:48am ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-5.53%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book3.56

Competitors

 Today’s
change
Today’s
% change
PTGXProtagonist Therapeu...+0.19+1.39%
TOCATocagen Inc+0.17+1.53%
PIRSPieris Pharmaceutica...+0.04+0.69%
ONVOOrganovo Holdings In...-0.00-0.21%
Data as of 11:04am ET, 07/25/2017

Financials

Next reporting dateAugust 25, 2017
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts